These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview. McCarberg BH; Barkin RL Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938 [TBL] [Abstract][Full Text] [Related]
4. On the pharmacological properties of Delta9-tetrahydrocannabinol (THC). Costa B Chem Biodivers; 2007 Aug; 4(8):1664-77. PubMed ID: 17712813 [TBL] [Abstract][Full Text] [Related]
5. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Izzo AA; Borrelli F; Capasso R; Di Marzo V; Mechoulam R Trends Pharmacol Sci; 2009 Oct; 30(10):515-27. PubMed ID: 19729208 [TBL] [Abstract][Full Text] [Related]
6. Phytocannabinoids as novel therapeutic agents in CNS disorders. Hill AJ; Williams CM; Whalley BJ; Stephens GJ Pharmacol Ther; 2012 Jan; 133(1):79-97. PubMed ID: 21924288 [TBL] [Abstract][Full Text] [Related]
7. Non-Δ⁹tetrahydrocannabinol phytocannabinoids stimulate feeding in rats. Farrimond JA; Whalley BJ; Williams CM Behav Pharmacol; 2012 Feb; 23(1):113-7. PubMed ID: 22157176 [TBL] [Abstract][Full Text] [Related]
8. The endocannabinoid system and its therapeutic exploitation. Di Marzo V; Bifulco M; De Petrocellis L Nat Rev Drug Discov; 2004 Sep; 3(9):771-84. PubMed ID: 15340387 [TBL] [Abstract][Full Text] [Related]
9. Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders. Scuderi C; Filippis DD; Iuvone T; Blasio A; Steardo A; Esposito G Phytother Res; 2009 May; 23(5):597-602. PubMed ID: 18844286 [TBL] [Abstract][Full Text] [Related]
10. Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Nigro E; Formato M; Crescente G; Daniele A Molecules; 2021 May; 26(9):. PubMed ID: 34063214 [No Abstract] [Full Text] [Related]
11. Endogenous cannabinoid system as a modulator of food intake. Cota D; Marsicano G; Lutz B; Vicennati V; Stalla GK; Pasquali R; Pagotto U Int J Obes Relat Metab Disord; 2003 Mar; 27(3):289-301. PubMed ID: 12629555 [TBL] [Abstract][Full Text] [Related]
12. Pharmacology of cannabinoids. Grotenhermen F Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677 [TBL] [Abstract][Full Text] [Related]
13. Endogenous cannabinoids and appetite. Kirkham TC; Williams CM Nutr Res Rev; 2001 Jun; 14(1):65-86. PubMed ID: 19087417 [TBL] [Abstract][Full Text] [Related]
14. The neurobiology and evolution of cannabinoid signalling. Elphick MR; Egertová M Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486 [TBL] [Abstract][Full Text] [Related]
15. Cannabis: pharmacology and toxicology in animals and humans. Adams IB; Martin BR Addiction; 1996 Nov; 91(11):1585-614. PubMed ID: 8972919 [TBL] [Abstract][Full Text] [Related]
16. Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways. Verhoeckx KC; Korthout HA; van Meeteren-Kreikamp AP; Ehlert KA; Wang M; van der Greef J; Rodenburg RJ; Witkamp RF Int Immunopharmacol; 2006 Apr; 6(4):656-65. PubMed ID: 16504929 [TBL] [Abstract][Full Text] [Related]
17. Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. Bonini SA; Premoli M; Tambaro S; Kumar A; Maccarinelli G; Memo M; Mastinu A J Ethnopharmacol; 2018 Dec; 227():300-315. PubMed ID: 30205181 [TBL] [Abstract][Full Text] [Related]
19. Phytocannabinoids beyond the Cannabis plant - do they exist? Gertsch J; Pertwee RG; Di Marzo V Br J Pharmacol; 2010 Jun; 160(3):523-9. PubMed ID: 20590562 [TBL] [Abstract][Full Text] [Related]
20. [Therapeutic applications and biomedical effects of cannabinoids; pharmacological starting points]. Killestein J; Nelemans SA Ned Tijdschr Geneeskd; 1997 Aug; 141(35):1689-93. PubMed ID: 9543785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]